Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in

  News Archive

Leading Industry Experts to Present at Lonza’s 2nd Global Endotoxin Testing Summit
Tuesday, March 01, 2016
A growing list of industry experts have signed up to join the speaker panel at Lonza’s 2nd Global Endotoxin Testing Summit from 23-25 May 2016, Annapolis, MD, and Pickering Beach, DE (USA).

Ubiquigent Strengthens Team to Deliver Cutting Edge Drug Discovery Services
Thursday, February 25, 2016
Ubiquigent has announced that it has significantly enhanced its drug discovery service capabilities by strengthening its commercial and chemistry teams to deliver an even more comprehensive range of services to the global life science research community.

Powerful Drug for Familial Amyloidosis
Thursday, February 25, 2016
The molecule has proved in preclinical trials to be up to four times more effective than the only pharmacological treatment currently available for familial transthyretin amyloidosis, a rare degenerative disease, and has already been tested in a clinical trial with patients.

Measuring Oxygen Levels in 3D Cells
Wednesday, February 24, 2016
Scientists at Plymouth University and AstraZeneca assessed the gradient of oxygen concentration within 3D cell cultures.

Breaking the Chain
Tuesday, February 23, 2016
Compound prevents multidrug-resistant fungi from pumping out drugs.

Secret to Promising New Cancer Drug Discovered
Tuesday, February 23, 2016
Researchers have resolved a mystery about how a promising new class of anti-cancer drugs, called nutlins, work - paving the way for improving the future of cancer treatment.

BioAgilytix Acquires IPM Biotech
Tuesday, February 23, 2016
BioAgilytix has announced the acquisition of IPM Biotech, a German-based bioanalytical contract research laboratory renowned for its expertise in large molecule bioanalysis, particularly in the area of immunogenicity.

Myriad Expands Collaboration with TESARO, Merck
Tuesday, February 23, 2016
Companion diagnostic portfolio to evaluate treatment response in patients with triple negative breast cancer or ovarian cancer.

Core Symptom of Schizophrenia Eliminated
Friday, February 19, 2016
Team uses chemical compound to restore affected brain regions; findings could lead to new treatment strategies.

<< 6 7 8 9 10 11 12 >>
Showing Results 81 - 90 of 2936
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos